论文部分内容阅读
目的:观察脑苷肌肽注射液治疗糖尿病周围神经病变的临床疗效。方法:将我院收治的200例糖尿病周围神经病变患者均于血糖控制基础上分为两组,其中观察组为脑苷肌肽注射液联合甲钴胺静脉滴注,对照组仅为甲钴胺治疗,疗程均为21天,疗程结束后对200例患者治疗前、后的症状及神经传导速度等方面的变化进行统计分析。结果:观察组的100例糖尿病患者接受了脑苷肌肽注射液与甲钴胺注射液联合治疗后,临床症状、体征及运动、感觉神经传导速度等方面治疗效果较对照组更显著,差异具有显著性(P<0.01)。结论:脑苷肌肽注射液能够用于糖尿病神经病变治疗,且疗效显著。
Objective: To observe the clinical effect of cinobufagin injection on diabetic peripheral neuropathy. Methods: 200 patients with diabetic peripheral neuropathy admitted to our hospital were divided into two groups on the basis of blood glucose control. The observation group was treated with intravenous injection of cerebroside and mecobalamin, while the control group was only mecobalamin , The course of treatment was 21 days after the end of treatment on 200 patients before and after treatment, the symptoms and nerve conduction velocity changes and other statistical analysis. Results: After treatment with 100 mg of glycoside and mecobalamin, the clinical symptoms, signs, motor and sensory nerve conduction velocity in the observation group were more significant than those in the control group. The difference was significant (P <0.01). Conclusion: CGN injection can be used in the treatment of diabetic neuropathy with significant curative effect.